BACKGROUND In the United States, the burden of human papillomavirus (HPV)‐associated
cancers varies by racial/ethnic group. HPV vaccination may provide opportunities for primary …

Objectives Human papillomavirus (HPV) is a common virus that currently infects nearly 80
million people in the United States (US) and can lead to cancer. HPV vaccination provides …

Human papillomavirus (HPV) causes roughly 1.6% of the plus 1.6 million cases of cancer
that are diagnosed in the United States each year. Despite the proven safety and efficacy of …

ABSTRACT In 2018, the Food and Drug Administration expanded the age of eligibility for the
human papillomavirus (HPV) vaccine to 27 to 45 years. However, it is unclear if there are …

Studies disagree about whether racial and ethnic groups have lower or higher human
papillomavirus (HPV) vaccination uptake, an important issue given large disparities in some …

Background We assessed disparities in HPV vaccination coverage by sociodemographic
characteristics in the United States. Methods Using 2017-March 2020 National Health and …

Human papillomavirus (HPV) causes cervical as well as other cancers. Racial and ethnic
disparities in cervical cancer incidence and mortality in the United States are well …

Postmarket surveillance of the incidence of human papillomavirus (HPV)–related cancers is
essential to monitor the effectiveness of HPV vaccines. We directly compared HPV-related …

Background Human papillomavirus (HPV) is associated with poor health outcomes,
including cervical cancer. Racial/ethnic minority populations experience poor health …

Importance Nearly 45 000 human papillomavirus (HPV)-associated cancers are diagnosed
annually in the US. The HPV vaccine has been approved since 2006, but information on the …